Trial
NCT02269566
Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Gachon University Gil Medical Center
Collaborators
Thermo Fisher Scientific, Inc
Condition
Allergic Rhinitis
Intervention
HollisterStier
Why stopped
The number of enrolled subjects did not meet the goal during the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-11